Kroger Launches Eli Lilly's New Drug Zepbound KwikPen
The Kroger Co. (KR) and The Kroger Family of Pharmacies announced that as part of its continued commitment to expanding access to high-demand GLP-1 therapies, Zepbound KwikPen, the newly launched, multi-dose delivery option of Eli Lilly's (LLY) weight-management medication, is now available at participating Kroger pharmacies, bringing patients a more convenient option for obtaining their medication.
